Sanford Canby Medical Center

CLIA Laboratory Citation Details

2
Total Citations
4
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 24D0405465
Address 112 St Olaf Ave S, Canby, MN, 56220
City Canby
State MN
Zip Code56220
Phone(507) 223-7277

Citation History (2 surveys)

Survey - July 17, 2024

Survey Type: Standard

Survey Event ID: PIU811

Deficiency Tags: D0000 D6045 D6051

Summary:

Summary Statement of Deficiencies D0000 The Sanford Canby Medical Center laboratory was found to be out of compliance with the regulations of the Clinical Laboratory Improvement Amendments of 1988 (42 C.F.R. part 493) upon completion of the recertification survey performed on July 16, 2024 and July 17, 2024. The following standard-level deficiencies were cited: 493.1413(b)(7) Technical consultant responsibilities 493.1413(b)(8)(v) Technical consultant responsibilities . D6045 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(7) (b) The technical consultant is responsible for-- (b)(7) Identifying training needs and assuring that each individual performing tests receives regular in-service training and education appropriate for the type and complexity of the laboratory services performed; This STANDARD is not met as evidenced by: . Based on observation, document review, and interview with laboratory personnel, the Technical Consultant failed to ensure initial training and competency assessment for one of one new testing personnel (TP) was performed and documented in 2023. Findings are as follows: 1. The laboratory performed moderate complexity Microbiology testing as confirmed by the General Supervisor (GS) during a tour of the laboratory at 1:05 p.m. on 07/16/24. 2. A Cepheid GeneXpert molecular diagnostic system was observed as present and available for use during the tour. The laboratory performed Influenza A, Influenza B, Respiratory Syncytial Virus, SARS CoV-2, and Streptococcus A testing using this system. 3. Competency evaluation of new testing personnel was required prior to testing specimens independently as established in the Competency Assessment - Canby procedure found in the laboratory's electronic procedure software, PolicyTech. 4. TP6 was approved by the laboratory director to perform testing using the GeneXpert system in May 2023 as indicated in laboratory records. 5. GeneXpert system initial training and competency Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- evaluation documents for TP6 were not found in laboratory records. The laboratory was unable to provide the missing training record and competency evaluation upon request. 6. In an interview at 5:45 p.m. on 07/16/24, the GS confirmed the above finding. . D6051 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(8)(v) The procedures for evaluation of the competency of the staff must include, but are not limited to assessment of test performance through testing previously analyzed specimens, internal blind testing samples or external proficiency testing samples. This STANDARD is not met as evidenced by: . Based on observation, document review, and interview with laboratory personnel, the Technical Consultant (TC) failed to ensure one of one new testing personnel (TP) was assessed semi-annually through testing previously analyzed specimens, blind samples, or proficiency testing samples in 2023. Findings are as follows: 1. The laboratory performed Microbiology, Chemistry, Diagnostic Immunology, and Hematology testing as confirmed by the General Supervisor (GS) during a tour of the laboratory at 1:05 p.m. on 07/16/24. 2. The following test systems were observed as present and available for use during the tour: Cepheid GeneXpert molecular test system Abbott Architect ci4100 general chemistry and immunoassay analyzer Stago Satellite coagulation analyzer Sysmex XN-550 hematology analyzer Olympus BH-2 microscopes - used for microscopic examinations for fungus, parasites, bacteria, manual differentials, and urine sediment BioRad ToxSee and Amnisure testing kits 3. Assessment of test performance using previously analyzed specimens, internal blind samples, or external proficiency samples was a required element of testing personnel competency assessment as established in the Competency Assessment - Canby procedure found in the laboratory's electronic procedure software, PolicyTech. 4. Testing personnel 6 (TP6) was approved by the laboratory director to perform testing using the GeneXpert system in May 2023 as indicated in laboratory records. Initial training and competency documents for this test system were not found in laboratory records for TP6. See D6045. 5. Initial training and competency documentation for the test systems listed above, with the exception of the Cepheid GeneXpert, were completed in September 2023. 6. Blind sample assessments were not included on TP6's 2023 semi-annual competency evaluation forms completed in December 2023 for the above test systems. The laboratory was unable to provide the missing blind sample evaluation documentation upon request. 7. In an interview at 5:45 p.m. on 07 /16/24, the GS confirmed the above finding. . -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - December 9, 2020

Survey Type: Standard

Survey Event ID: E2KP11

Deficiency Tags: D5537

Summary:

Summary Statement of Deficiencies D5537 ROUTINE CHEMISTRY CFR(s): 493.1267(b)(d) For blood gas analyses, the laboratory must perform the following: (b) Test one sample of control material each 8 hours of testing using a combination of control materials that include both low and high values on each day of testing. (d) Document all control procedures performed, as specified in this section. This STANDARD is not met as evidenced by: . Based on document review and interview with laboratory personnel, the laboratory failed to test at least 1 level of quality control (QC) material each 8 hours of operation on a Chemistry (blood gas) analyzer from July 2018 through December 2020. Findings include: 1. The laboratory performed Arterial Blood Gas testing on the AVL OPTI Critical Care Analyzer as indicated on the Tests Performed by SCMC policy provided by the laboratory via email on 12/01/20. 2. Quality control (QC) testing for blood gas analysis was established as 3 levels of QC material every 24 hours of testing as indicated in the Blood Gas General Procedure Cover document provided by the laboratory on 12/03/20. 3. An Individualized Quality Control Plan (IQCP) to reduce the required frequency of blood gas QC performance from every 8 hours of operation was not included in blood gas analysis documents and testing records provided by the laboratory on 12/03/20 and 12/04/2020. 4. In email communication received at 2:56 p.m. on 12/08/20, the General Supervisor confirmed the laboratory performed blood gas QC once every 24 hours. An IQCP for blood gas analysis was not provided. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access